Alerts will be sent to your verified email
Verify Email
SENORES
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.21 % | 21.63 % | 12.89 % |
|
5yr Avg Net Profit Margin
|
15.17 % | 19.77 % | 11.15 % |
|
Price to Book
|
4.11 | 8.08 | 3.56 |
|
P/E
|
55.18 | 32.94 | 30.68 |
|
5yr Avg Cash Conversion Cycle
|
-69.14 Days | -102.34 Days | 9.46 Days |
|
5yr Average Interest Coverage Ratio
|
4.49 | 108.5 | 30.59 |
|
5yr Avg ROCE
|
10.49 % | 27.48 % | 15.26 % |
|
5yr Avg Operating Profit Margin
|
23.01 % | 27.65 % | 17.29 % |
|
5 yr average Debt to Equity
|
0.98 | 0.0 | 0.14 |
|
5yr CAGR Net Profit
|
99.71 % | 7.08 % | -12.64 % |
|
5yr Average Return on Assets
|
4.43 % | 16.51 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.78 % | 66.26 % | 69.67 % |
|
Share Pledged by Promoters
|
0.0 | 14.12 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.02 % | -4.22 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.62 % | 3.84 % | 4.04 % |
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|---|